Depression Medications Causing My Bad Dreams?

I'm a 64-year-old manly being treated for major recession and anxiety. My treatment consists of cognitive remedy and three prescription medications. My puzzle is a recurring, frustrating dream in which I'm trapped at bottom a stone maze with no way out. This has on tons occasions caused early-morning downturn prior to my meds taking truly. My question is, are these disturbing dreams symbolic of other problems yet to be addressed, or could they be a come about of my meds? I would appreciate your input, as this job has become very stressful.
Depression is associated with an enlarge in the amount and intensity of instantaneous eye movement sleep, which is the physiological asseverate in which most dreams befall. There is some predisposition for depressed people to feel more-distressing dreams than people who are not depressed; these as per usual reflect themes that are in agreement with the worries and difficulties that squire the depressive state. Although most depressed people do not shot experiencing recurring nightmares or bad dreams, what you’re describing does not uninterrupted out of the ordinary; a sense of entrapment and powerlessness to clear up problems is very prevalent in depression. 
The surrebuttal to your question up whether your medication is causing or intensifying your iterative dream can be partly organize in your history. If the recurring dreams began after you started attractive the medication, it is more qualified that your medication is playing some function, buy generic Valium. Most, although not all, antidepressants change the amount of REM sleep you get every unceasingly and tend to “prompt” dream slumber into the latter large of a night’s sleep. Because we typically commemorate best our last pipedream (that is, the one that we occurrence closest to awakening), a medication that concentrates delusion sleep at the end of the night can be associated with bad dreams or nightmares.
Because you're having these distressing dreams, it may be irreproachable to talk with your doctor around possible alternate medications. Although irregular dreams have been reported as side effects of effectively all antidepressant medications, the ones that prepare less of a suppressing effect on REM siesta include bupropion (Wellbutrin, Zyban, Budeprion), Serzone (nefazodone), Desyrel (trazodone), Remeron (mirtazapine), and buy Valium. Aside from bupropion, these medications also be suffering with
stronger effects than other antidepressants for treating insomnia. 

Mindfulness Therapy Rivals Drugs for Treating Depression Relapse

Canadian researchers conducted a study comparing standard antidepressant medication to cognitive therapy and placebo, finding the treatment rivals medication for preventing depression relapse. Mindfulness based cognitive therapy (MBCT) worked just as well as medications for a group of patients who have unstable remission after being treated for depression.

Mindfulness-Based Cognitive Therapy Compared to Antidepressants

The findings, reported in the Archives of General Psychiatry, found that teaching depressed patients to focus on that promote health such as Yoga and meditation removes focus on symptoms, leading to fewer relapses.
Out of a group of 166 patients, 84 had achieved remission and received mindfulness-based cognitive therapy, antidepressants or placebo.
The group chosen for cognitive behavioral therapy discontinued antidepressant medications and attended one group session for 8 weeks. During initial treatment, 51 percent were found to have depression relapse.
"Our findings indicated that the quality of remission achieved during the acute phase interacted with the type of prevention treatment patients received to determine relapse outcomes during the subsequent maintenance phase," the researchers wrote.
A comparison was then made between the three groups of unstable depression patients, showing cognitive based therapy worked as well as taking medication – specifically 28 percent for mindfulness therapy, 27 percent for antidepressant medications and 71 percent for placebo.
The authors write, "For patients whose acute-phase remission was marked by periodic symptom flurries”, mindfulness-based cognitive therapy and antidepressants individually, “significantly lowered relapse/recurrence risk compared with discontinuation to placebo."
The researchers note, “Surprisingly, for patients whose acute-phase remission was stable, there was no differential effect on survival between the treatments we studied.”
The findings, according to the authors, emphasize the “importance maintaining at least 1 long-term active treatment in unstable remitters.” For patients who poorly tolerate antidepressants, mindfulness-based cognitive therapy was found to work as well as medications to prevent depression relapse.